itraconazole and Cytomegalovirus Infections

itraconazole has been researched along with Cytomegalovirus Infections in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bleibtreu, A; Diamantis, S; Grégoire, V; Lehur, AC; Picard, A; Pluvy, J; Rioux, C; Vallois, D; Zielinski, M1
Amat, P; Benet, I; Bravo, D; Clari, MÁ; Costa, E; Giménez, E; Muñoz-Cobo, B; Navarro, D; Nieto, J; Remigia, MJ; Solano, C1
Bando, T; Chen, F; Date, H; Hotta, G; Ichiyama, S; Ito, Y; Kato, K; Matsubara, K; Matsuda, Y; Matsumura, Y; Nagao, M; Nakano, S; Takakura, S; Yamamoto, M; Yunoki, T1
Ando, K; Fukushima, T; Hata, T; Honda, S; Imaizumi, Y; Imanishi, D; Itonaga, H; Matsuo, E; Miyazaki, Y; Moriuchi, Y; Onimaru, Y; Sato, S; Sawayama, Y; Taguchi, J; Tsushima, H; Yamasaki, R; Yoshida, S1
Bouza, E; Desco, M; Domínguez, MJ; Muñoz, P; Palomo, J; Rodríguez, C; Yañez, JF1
Cheng, B1

Other Studies

7 other study(ies) available for itraconazole and Cytomegalovirus Infections

ArticleYear
Case of disseminated histoplasmosis in a HIV-infected patient revealed by nasal involvement with maxillary osteolysis.
    BMC infectious diseases, 2017, 05-05, Volume: 17, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; CD4 Lymphocyte Count; Cytomegalovirus Infections; Diagnosis, Differential; Female; Haiti; Histoplasmosis; HIV Infections; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Maxillary Diseases; Middle Aged; Osteolysis

2017
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
    Journal of medical virology, 2014, Volume: 86, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Echinocandins; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Phosphoproteins; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Superinfection; Transplantation, Homologous; Triazoles; Viral Matrix Proteins; Voriconazole; Young Adult

2014
Itraconazole prophylaxis for invasive Aspergillus infection in lung transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:2

    Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Case-Control Studies; Cytomegalovirus Infections; Female; Humans; Itraconazole; Lung Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Renal Replacement Therapy; Retrospective Studies; Risk Factors; Tracheotomy

2014
Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2013, Volume: 19, Issue:4

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Bacterial Infections; Cytomegalovirus Infections; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Japan; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Survival Analysis; Transplantation, Homologous

2013
Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004, Volume: 4, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Cytomegalovirus; Cytomegalovirus Infections; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Itraconazole; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Proportional Hazards Models; Regression Analysis; Risk; Risk Factors; Time Factors; Treatment Outcome

2004
Drugs for AIDS and associated infections.
    The Medical letter on drugs and therapeutics, 1995, Oct-13, Volume: 37, Issue:959

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine

1995
Preventing opportunistic infections.
    PI perspective, 1995, Issue:no 16

    Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as Topic; Clotrimazole; Cytomegalovirus Infections; Dapsone; Fluconazole; Ganciclovir; Humans; Itraconazole; Leucovorin; Mycobacterium avium-intracellulare Infection; Mycoses; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Valacyclovir; Valine

1995